New: Hyperplex Biomarker Panels
Custom Panels for Absolute Protein Quantification
New: Hyperplex Biomarker Panels
Custom Panels for Absolute Protein Quantification
Global Headquarters for R&D and Innovation, offering our full portfolio of CRO services
Discovery proteomics services for US customers
In our state-of-the-art facilities of in total >1,500 square meters (>15,000 square feet), we can handle large volumes of samples, while maintaining our unprecedented precision and depth. We can deliver many projects in parallel and routinely perform studies with over 1,000 samples for global pharma and biotech customers, academia, or consortia.
We process and store data with utmost protection and operate under comprehensive quality standards. Our Quality Management System (QMS) follows the Organisation for Economic Co-operation and Development (OECD) GLP guidelines and is GCP compliant. This allows us to support our customers in the implementation of proteomics in clinical trials.
We stand for flexibility as well as scalability. We are flexible to support projects of different sizes and sample numbers, depending on the customer’s need. We operate at large scale according to today’s standards, and we are also fully equipped and capable to continuously scale up our throughput to support the rising capacity needs for large-scale proteomics in the future.
Our lab facilities are operated by highly trained personnel with multiple years of proteomics expertise and extensive experience in the handling of various types of projects. Our lab personnel continuously develop and maintain our facilities for optimal performance and uptime.
Our high-end mass spectrometers are set up with automated, tight spaced quality control. They can process samples from any species or biological matrices with high reproducibility.
For pre-clinical studies, our facilities follow the OECD GLP guidelines. For clinical studies, we comply with GCP guidelines based on ICH E6 and the EMA reflection paper for laboratories that perform the analysis or evaluation of clinical trial samples.
Our IT infrastructure guarantees timely, error-free, and secure transfer of the mass spectrometric data. The resilient, in-house storage platform is prepared for huge future storage growth.
From our two facilities, we invent and develop proprietary mass spectrometry-based proteomics technologies and offer a broad range of cutting-edge proteomics solutions. We make these widely available to life science researchers and proteomics experts to make the proteome more accessible.
Biognosys AG
Wagistrasse 21
8952 Schlieren
Switzerland
Phone: +41 44 738 20 40
US Offices
Biognosys Inc
70 Bridge St, Suite 104
Newton, MA 02458
United States
